India’s Natco Mulls HIV/AIDS Antiviral, Other Drugs For Next CL Attempt
This article was originally published in PharmAsia News
Natco Pharma, fresh from getting India’s first compulsory license to produce a generic of a patent-covered branded drug, is looking for other treatments considered life-saving for additional CLs.
You may also be interested in...
UK HTA body NICE is looking to the future and rethinking its approach to data and how they inform its guidance.
Slovenia’s Krka has responded to media reports of “irregularities” at its Romanian subsidiary – including allegations of bribing local doctors to prescribe its products – by pledging to form a special investigation team to immediately examine the matter.